EARNEST PARTNERS LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 206 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
EARNEST PARTNERS LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$198
-12.8%
80.0%0.00%
Q2 2023$227
+23.4%
80.0%0.00%
Q1 2023$184
-18.2%
80.0%0.00%
Q4 2022$22580.0%0.00%
Q3 2022$080.0%0.00%
Q2 2022$080.0%0.00%
Q1 2022$080.0%0.00%
Q4 2021$080.0%0.00%
Q3 2021$080.0%0.00%
Q2 2021$080.0%0.00%
Q1 2021$080.0%0.00%
Q4 2020$080.0%0.00%
Q3 2020$080.0%0.00%
Q2 2020$080.0%0.00%
Q1 2020$080.0%0.00%
Q4 2019$080.0%0.00%
Q3 2019$080.0%0.00%
Q2 2019$0
-100.0%
80.0%0.00%
Q1 2019$1,00080.0%0.00%
Q4 2018$0
-100.0%
80.0%0.00%
Q3 2018$1,0000.0%80.0%0.00%
Q2 2018$1,0000.0%80.0%0.00%
Q1 2018$1,00080.0%0.00%
Q4 2017$080.0%0.00%
Q4 2016$080.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders